Open Orphan’s order book reflects booming challenge study market, says Proactive analyst

Proactive analyst, Daniel Appiah, discusses with Chris Rhodes his latest assessment of Open Orphan.

The company now has challenge studies running in 10 different infections/conditions with new models being developed and added all the time, including asthma and malaria models.

Its contract order book stands at over £80mln — almost three times the value a year ago.

You might like

© 2022 The Latest StockMarket News and Interviews